ASTRAZENECA PLC-SPONS ADR (AZN)

US0463531089 - ADR

70.13  +1.58 (+2.3%)

After market: 70.1991 +0.07 (+0.1%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ASTRAZENECA PLC-SPONS ADR

NASDAQ:AZN (4/22/2024, 7:00:01 PM)

After market: 70.1991 +0.07 (+0.1%)

70.13

+1.58 (+2.3%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap217.43B
Shares
PE19.11
Fwd PE16.53
Dividend Yield2.28%
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AZN Daily chart

Company Profile

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company is headquartered in Cambridge, Cambridgeshire and currently employs 83,500 full-time employees. The company went IPO on 2007-09-21. The firm focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. Its geographical segments include United Kingdom, Rest of Europe, the Americas and Asia, Africa and Australasia. The company is also focused on discovering, developing, and manufacturing of T-cell receptor therapies.

Company Info

ASTRAZENECA PLC-SPONS ADR

1 Francis Crick Avenue

Cambridge CAMBRIDGESHIRE CB2 0AA

P: 442073045000

CEO: Pascal Soriot

Employees: 83500

Website: https://www.astrazeneca.com/

AZN News

News Image4 days ago - InvestorPlace3 Blue-Chip Stocks to Buy as High Inflation Persists

These are the undervalued blue-chip stocks for inflation protection, with the Fed likely to delay the first interest rate cut.

News Image5 days ago - AB NewswireNavigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
News Image7 days ago - AstraZenecaIMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
News Image7 days ago - InvestorPlace3 Pharma Stocks That Are Money-Printing Machines in 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

News Image9 days ago - The Motley Fool4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Amazing deals can still be found by opportunistic investors, even with the Nasdaq Composite reaching new heights.

News Image11 days ago - FinancialNewsMediaBiotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

AZN Twits

Here you can normally see the latest stock twits on AZN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example